News

New cancer treatment approved in Australia

(19 Dec 18) Novartis Australia has announced the TGA approval of Kymriah® (tisagenlecleucel), for the…

Cell TherapiesDecember 19, 2018

News

Dr Dawn Driscoll appointed as CEO at Cell Therapies Pty Ltd

Cell Therapies Pty Ltd is delighted to announce the appointment of Dr Dawn Driscoll as…

Cell TherapiesOctober 4, 2017

News

CTPL awarded Australian Global Innovation Linkages programme grant

Melbourne, Australia 26 June 2017: Cell Therapies has been awarded $1,000,000 in funding by the…

Cell TherapiesJune 26, 2017

News

CTPL receives APAC Bioprocessing Excellence Award

Melbourne, Australia 20 February 2017: Cell Therapies commitment to, and excellence in, bringing innovative cellular…

Cell TherapiesFebruary 20, 2017

News

CTPL CEO, Tim Oldham, elected to Alliance for Regenerative Medicine 2017 Board of Directors

Melbourne, Australia, 11 October 2016: Cell Therapies Pty Ltd (CTPL) is pleased to announce that…

Cell TherapiesOctober 26, 2016

News

ISCT 2016

CT's contribution to ISCT 2016 Representatives from Cell Therapies presented at ISCT Singapore on the…

Cell TherapiesAugust 19, 2016

News

Apheresis for cellular therapy manufacturing: need for improved collection data

Melbourne 8 Feb 2016: Cell collection via apheresis is the starting point for manufacture of…

Cell TherapiesFebruary 8, 2016

News

Reform Needed To Fulfill Our Biotech Potential

REFORM NEEDED TO FULFILL OUR BIOTECH POTENTIAL is an article by AusBiotech’s Chief Executive, Dr…

Cell TherapiesOctober 7, 2015

News

Confirmation of BioNexus Award to CTPL

Melbourne and Kuala Lumpur 30 Sep 2015: Cell Therapies Pty Ltd (CTPL) has today received…

Cell TherapiesOctober 5, 2015

News

CTPL CSO Dominic Wall comments on opportunities and challenges of CAR-T therapy in lead-up to AusBiotech 2015

Cell Therapies’ Chief Scientific Officer, Dr Dominic Wall will participate in AusBiotech2015 as part of…

Cell TherapiesSeptember 25, 2015

News

CTPL featured in Australasian Biotechnology Advanced Manufacturing Feature

Cell Therapies Pty Ltd has been profiled in Australian Biotechnology’s most recent edition featuring advanced…

Cell TherapiesSeptember 22, 2015

News

New alliance to deliver pan-Asian cell processing capability to further the regenerative medicine and cellular therapy industry

Nagoya, Japan and Melbourne, Australia: 28 April 2015: PharmaBio Ltd and Cell Therapies Pty Ltd…

Cell TherapiesApril 28, 2015

Filter

ACTRIS Signs MoU with Cell Therapies Pty Ltd to Advance CDMO Capabilities for Cell and Gene Therapies

Cell Therapies and ENCell Forge Strategic APAC Partnership to Advance Cell and Gene Therapy Manufacturing

A-SEEDS and Cell Therapies Announce Manufacturing Partnership to Advance Clinical Trials of Novel CAR-T Cell Therapy

News

New cancer treatment approved in Australia

Dr Dawn Driscoll appointed as CEO at Cell Therapies Pty Ltd

CTPL awarded Australian Global Innovation Linkages programme grant

CTPL receives APAC Bioprocessing Excellence Award

CTPL CEO, Tim Oldham, elected to Alliance for Regenerative Medicine 2017 Board of Directors

ISCT 2016

Apheresis for cellular therapy manufacturing: need for improved collection data

Reform Needed To Fulfill Our Biotech Potential

Confirmation of BioNexus Award to CTPL

CTPL CSO Dominic Wall comments on opportunities and challenges of CAR-T therapy in lead-up to AusBiotech 2015

CTPL featured in Australasian Biotechnology Advanced Manufacturing Feature

New alliance to deliver pan-Asian cell processing capability to further the regenerative medicine and cellular therapy industry

Unrivalled experience and service from a global leader in cell and gene therapy manufacturing

Services

Helpful Links

Corporate